Intercept Pharmaceuticals Inc (NASDAQ:ICPT)
| 34.36 Data as of May 24 |  +0.19 / +0.56%Today’s Change | 17.96 Today|||52-Week Range 42.67 | +0.35% Year-to-Date |
Latest ICPT News | Press Releases
No recent news for Intercept Pharmaceuticals Inc.
Today’s Trading
| Previous close | 34.17 |
| Today’s open | 34.33 |
| Day’s range | 34.24 - 34.51 |
| Volume | 20,763 |
| Average volume (3 months) | 34,348 |
| Market cap | $577.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -809.09% |
| Earnings growth (this year) | +74.02% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +35.51% |
| P/E ratio | NM |
| Price/Sales | 87.95 |
| Price/Book | 8.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CCXIChemoCentryx Inc | -0.02 | -0.14% |
| CMRXChimerix Inc | +1.07 | +5.16% |
| LGNDLigand Pharmaceutica... | -0.48 | -1.72% |
| OREXOrexigen Therapeutic... | -0.03 | -0.46% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $2.4M |
| Annual profit (last year) | -$43.6M |
| Net profit margin | -1,784.19% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Mark E. Pruzanski, MD |
Chief Financial Officer, Secretary & Treasurer Barbara Gayle Duncan, MBA, CPA |
Corporate headquarters New York, New York |
Forecasts
